AMA CXO Todd Unger discusses the latest research on long COVID with Akiko Iwasaki, PhD, the Sterling Professor of Immunobiology at Yale University and a principal investigator at the Howard Hughes Medical Institute.
Apr 11, 2022•15 min•Ep. 139
AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the spread of the BA2 variant, Medicare paying for at-home COVID tests, as well as the latest from the FDA and CDC regarding who may get a second COVID booster shot.
Apr 06, 2022•13 min•Ep. 138
For more resources and access to “A Physician Guide to Keeping Your Practice Open During the Ongoing COVID-19 Pandemic,” visit: ama-assn.org/KeepPracticeOpenGuide
Apr 05, 2022•18 min•Ep. 137
AMA CXO Todd Unger reflects on #SaveYourVisionMonth with David Aizuss, MD, an ophthalmologist in Los Angeles and an AMA trustee, who shares what physicians want you to know about how the pandemic may be affecting your eye health and the importance of regular eye care from a physician.
Apr 04, 2022•12 min•Ep. 136
AMA CXO Todd Unger reviews COVID-19 trending topics and news related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the FDA's authorization of a second booster shot, as well as changes in COVID treatments and therapies. Additionally, uninsured patients may have to pay high prices out-of-pocket for COVID tests and vaccinations due to lack of federal funding and stalled budget approval.
Mar 29, 2022•12 min•Ep. 135
AMA CXO Todd Unger reviews COVID-19 news and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering what we know about the BA.2 Omicron subvariant, if a new surge is coming soon, the latest on booster shots and changing data collection on the pandemic.
Mar 23, 2022•15 min•Ep. 134
AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering state-wide mandates lifting for masks in school, and the latest developments on when a COVID vaccine will be available for kids under 5.
Mar 16, 2022•13 min•Ep. 133
AMA CXO Todd Unger talks with AMA President Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., who shares five actions we can take now to fix our ailing health care system and rebuild trust.
Mar 10, 2022•22 min•Ep. 132
AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the government's newly released COVID response strategy and how it will take the nation out of crisis mode, the CDC's scaled back contact tracing efforts and the U.S. Surgeon General's renewed push to fight misinformation online.
Mar 09, 2022•14 min•Ep. 131
AMA CXO Todd Unger talks with Stephen Parodi, MD, the executive vice president of external affairs, communications and brand at The Permanente Federation, and associate executive director for The Permanente Medical Group in Oakland, Calif., about pandemic vs. endemic and what that shift will mean for our COVID-19 response.
Mar 07, 2022•23 min•Ep. 130
AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering new data from CDC studies, understanding community risk and finding your local COVID-19 Community Level, as well as positive long-lasting effects of COVID booster shots. Access the Centers for Disease Control and Prevention's "COVID-19 by County" tracker here: https://www.cdc.gov/coronavirus/2019-ncov...
Mar 02, 2022•14 min•Ep. 129
AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the latest on coronavirus treatments, including Merk's COVID pill, as well as research outlining the positive effects of getting vaccinated during pregnancy.
Feb 23, 2022•14 min•Ep. 128
In part three of this three-part series, Aimee Hodowanec, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what physicians need to know about Molnupiravir as treatment for COVID-19.
Feb 18, 2022•13 min•Ep. 127
AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the FDA's pivot to wait for more data on vaccines for kids under 5, and what new data from the CDC tells us about booster shots.
Feb 16, 2022•12 min•Ep. 126
In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.
Feb 15, 2022•15 min•Ep. 124
AMA CXO Todd Unger dives into new developments from ACIP's emergency meeting on Feb. 4 with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.
Feb 14, 2022•13 min•Ep. 125
AMA president Gerald Harmon, MD, welcomes experts from the U.S. Food and Drug Administration (FDA) to discuss what prescribers need to know about COVID-19 therapeutic drugs, Paxlovid and Molnupiravir. Alternative treatment options for high-risk outpatients with mild-moderate COVID-19 are also discussed. Guest: John Farley, MD, MPH, director, Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA
Feb 11, 2022•10 min•Ep. 123
Feb 09, 2022•14 min•Ep. 122
AMA CXO Todd Unger is joined by the AMA’s president, Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., who shares new information and big takeaways about therapeutics for COVID-19 after his recent conversation with three physician leaders from the FDA.
Feb 07, 2022•16 min•Ep. 121
AMA CXO Todd Unger talks with David Rubin, MD, director of PolicyLab at Children’s Hospital of Philadelphia and a professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania, about his team's nationally recognized COVID-19 forecasting model and how it informs new guidance for K-12 educational settings aimed at keeping kids in school.
Feb 03, 2022•18 min•Ep. 120
AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Including the new “stealth Omicron” variant, as well as data from the latest CDC study showing third doses/booster shots bolster COVID defenses for both the immunocompromised and people with stronger immune systems. Also recapping AMA's joint statement with the American Hospital Association (AHA) and the American N...
Feb 02, 2022•14 min•Ep. 119
AMA CXO Todd Unger talks with AMA President Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., about the important role physicians can play at this pivotal time in the pandemic and the support they need to do so.
Feb 01, 2022•20 min•Ep. 118
AMA CXO Todd Unger talks with Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children’s Hospital Center for Vaccine Development in Houston, to learn about his new COVID vaccine and how it fits into our global pandemic response.
Jan 31, 2022•17 min•Ep. 117
During #DataPrivacyWeek, AMA CXO Todd Unger talks with Laura Hoffman, JD, the AMA’s assistant director of federal affairs, about the importance of establishing guardrails for digital vaccination data and how physicians can address data privacy concerns with patients. Access the AMA's case for privacy by design in app development resource here: https://www.ama-assn.org/system/files/privacy-principles-by-design.pdf To learn more about AMA's health data privacy framework and advocacy work on the is...
Jan 27, 2022•20 min•Ep. 116
The webinar: "COVID-19: What to know about therapeutics and other treatment options" is scheduled for Tuesday, Feb. 1, at 3 p.m. Central time. Register and submit questions for the webinar here: https://www.ama-assn.org/delivering-care/public-health/covid-19-what-physicians-need-know-webinar-series
Jan 26, 2022•14 min•Ep. 115
AMA CXO Todd Unger discusses clinician well-being in the COVID “new normal" with Jonathan Ripp, MD, MPH, dean for well-being and resilience at the Icahn School of Medicine at Mount Sinai and chief wellness officer at Mount Sinai Health System.
Jan 25, 2022•15 min•Ep. 114
AMA CXO Todd Unger talks with Leana Wen, MD, MSc, public health professor at George Washington University, a columnist with the Washington Post, and a CNN medical analyst, about how physician communication and leadership can clear up COVID confusion for individual patients—as well as the nation.
Jan 24, 2022•19 min•Ep. 113
AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering developments in COVID hot spots across the nation, the CDC's clarified stance on masks, and Dr. Fauci's "five phases of the pandemic."
Jan 19, 2022•14 min•Ep. 112
AMA CXO Todd Unger talks with Leonard Nelson, JD, the AMA’s senior assistant general counsel, about the recent Supreme Court decisions on vaccine mandates and their long-term implications for physicians.
Jan 14, 2022•15 min•Ep. 111
AMA CXO Todd Unger reviews rising COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also detailing what physicians and patients need to know about the CDC’s updated guidance on isolation, quarantine and testing.
Jan 12, 2022•16 min•Ep. 110